Achieve Life Sciences Inc (SP4P) — Financial Flexibility Index
Achieve Life Sciences Inc (SP4P) has a Financial Flexibility Index of -0.31x as of March 2026. Free cash flow of €-6.93 Million (operating CF €-6.93 Million minus capex €0.00) represents 0% of total liabilities (€22.43 Million). Check Achieve Life Sciences Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Achieve Life Sciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Achieve Life Sciences Inc across 10 annual periods. For the full cash flow conversion analysis, see SP4P cash generation efficiency.
Annual Financial Flexibility Index for Achieve Life Sciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Achieve Life Sciences Inc. Explore Achieve Life Sciences Inc (SP4P) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.44x | €-49.46 Million | €-49.47 Million | €20.27 Million | ▼ -45.3% |
| 2024 | -1.68x | €-29.77 Million | €-29.77 Million | €17.73 Million | ▼ -42.9% |
| 2023 | -1.17x | €-24.46 Million | €-24.48 Million | €20.82 Million | ▲ +32.2% |
| 2022 | -1.73x | €-37.55 Million | €-37.55 Million | €21.67 Million | ▼ -14.6% |
| 2021 | -1.51x | €-29.44 Million | €-29.44 Million | €19.47 Million | ▲ +66.2% |
| 2020 | -4.47x | €-13.46 Million | €-13.47 Million | €3.01 Million | ▲ +10.8% |
| 2019 | -5.01x | €-15.16 Million | €-15.22 Million | €3.03 Million | ▼ -55.4% |
| 2018 | -3.22x | €-10.58 Million | €-10.62 Million | €3.28 Million | ▲ +28.4% |
| 2017 | -4.50x | €-9.06 Million | €-9.11 Million | €2.01 Million | ▼ -24437.5% |
| 2016 | -0.02x | €-156.00K | €-202.00K | €8.50 Million | — |